To determine the αCD40-mediated Batf3-independent antitumor mechanism, we measured tumor weights in Batf3–/– mice treated with CD40 agonist and the various immune cell depletions used in Figure 8, H and I. The gene discussed is CD40; the disease is neoplasm.